Predictive Oncology Inc. (POAI)

USD 0.98

(-11.71%)

Long Term Debt Summary of Predictive Oncology Inc.

  • Predictive Oncology Inc.'s latest annual long term debt in 2023 was 2.18 Million USD , up 2442.9% from previous year.
  • Predictive Oncology Inc.'s latest quarterly long term debt in 2024 Q1 was 2.02 Million USD , down -100.0% from previous quarter.
  • Predictive Oncology Inc. reported annual long term debt of 86.08 Thousand USD in 2022, down -64.08% from previous year.
  • Predictive Oncology Inc. reported annual long term debt of 239.66 Thousand USD in 2021, down -71.64% from previous year.
  • Predictive Oncology Inc. reported quarterly long term debt of 1.86 Million USD for 2024 Q2, down 0.0% from previous quarter.
  • Predictive Oncology Inc. reported quarterly long term debt of 2.18 Million USD for 2023 FY, up 2442.9% from previous quarter.

Annual Long Term Debt Chart of Predictive Oncology Inc. (2023 - 2008)

Historical Annual Long Term Debt of Predictive Oncology Inc. (2023 - 2008)

Year Long Term Debt Long Term Debt Growth
2023 2.18 Million USD 2442.9%
2022 86.08 Thousand USD -64.08%
2021 239.66 Thousand USD -71.64%
2020 845.12 Thousand USD 212.7%
2019 270.26 Thousand USD 0.0%
2018 - USD 0.0%
2017 - USD 0.0%
2016 - USD 0.0%
2015 - USD 0.0%
2014 - USD 0.0%
2013 - USD -100.0%
2012 89.3 Thousand USD -85.83%
2011 630.15 Thousand USD -37.41%
2010 1 Million USD 767.11%
2009 116.1 Thousand USD 17.99%
2008 98.4 Thousand USD 0.0%

Peer Long Term Debt Comparison of Predictive Oncology Inc.

Name Long Term Debt Long Term Debt Difference
Akoya Biosciences, Inc. 75.25 Million USD 97.091%
AngioDynamics, Inc. 3.93 Million USD 44.428%
AtriCure, Inc. 60.59 Million USD 96.387%
Avinger, Inc. - USD -Infinity%
Azenta, Inc. 60.43 Million USD 96.378%
BioLife Solutions, Inc. 18.31 Million USD 88.046%
The Cooper Companies, Inc. 2.52 Billion USD 99.913%
Daxor Corporation 755.65 Thousand USD -189.678%
Ekso Bionics Holdings, Inc. 4.83 Million USD 54.698%
Femasys Inc. 4.25 Million USD 48.594%
GlucoTrack, Inc. 196 Thousand USD -1016.826%
Harvard Bioscience, Inc. 30.7 Million USD 92.871%
Hologic, Inc. 2.49 Billion USD 99.912%
ICU Medical, Inc. 1.57 Billion USD 99.861%
Intuitive Surgical, Inc. -82.1 Million USD 102.666%
KORU Medical Systems, Inc. 3.65 Million USD 40.076%
LeMaitre Vascular, Inc. 16.62 Million USD 86.832%
Innovative Eyewear, Inc. - USD -Infinity%
Innovative Eyewear, Inc. - USD -Infinity%
Masimo Corporation 871.7 Million USD 99.749%
Microbot Medical Inc. 40 Thousand USD -5372.448%
Meihua International Medical Technologies Co., Ltd. 4592.00 USD -47569.403%
Merit Medical Systems, Inc. 823.01 Million USD 99.734%
Nephros, Inc. 1.39 Million USD -57.481%
NovoCure Limited 596.24 Million USD 99.633%
NEXGEL, Inc. 513 Thousand USD -326.702%
NEXGEL, Inc. 513 Thousand USD -326.702%
Singular Genomics Systems, Inc. 67.52 Million USD 96.758%
OraSure Technologies, Inc. 11.38 Million USD 80.778%
Pro-Dex, Inc. 7.53 Million USD 70.953%
Pulse Biosciences, Inc. 8.08 Million USD 72.929%
Precision Optics Corporation, Inc. 1.93 Million USD -12.952%
QuidelOrtho Corporation 2.27 Billion USD 99.904%
Repligen Corporation 510.14 Million USD 99.571%
Sanara MedTech Inc. 9.11 Million USD 75.98%
STAAR Surgical Company 31.46 Million USD 93.044%
Sharps Technology, Inc. - USD -Infinity%
Utah Medical Products, Inc. 295 Thousand USD -642.027%
DENTSPLY SIRONA Inc. 1.79 Billion USD 99.878%
Jin Medical International Ltd. - USD -Infinity%